Understanding pharma’s trust paradox: The role of social listening and strategic engagement
In 2024, the pharma industry found itself with a growing “trust paradox.” While innovations like gene therapies and rare disease […]
January 30, 2025
Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026
To help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated
Early Commercial Planning: Mitigate Patient Access Challenges for Cell and Gene Therapies
Cell and gene therapies (CGTs) offer fresh hope to patients with serious and debilitating diseases, often where no other treatment